Retatrutide

Description

Reta-trutide

Works by activating GLP-1, GIP, & glucagon receptors, which results in decreased food intake, delayed gastric emptying, improved glycemic control, and significant weight reduction.Triple agonist – targets GLP-1, GIP, and glucagon

Potent weight loss – up to 24% reduction in body weight at highest doses

Triple Receptor Activation: GLP-1, GIP, & glucagon agonism for a synergistic effect on both satiety & energy expenditure

• Superior control over appetite, fat metabolism, & blood glucose
• Improved glycemic control, reduced liver fat, & better lipid (cholesterol & triglyceride) profiles
• Cardiovascular & liver protection, showing positive effects on blood pressure & cholesterol, lowering cardiovascular risk factors
• Liver health improvements, including reduction of liver fats
• Pre-clinical data: may decrease kidney inflammation & fibrosis

This product is for research use only and is not intended for human consumption, diagnostic, or therapeutic purposes. It is to be used solely by qualified professionals in controlled laboratory settings. The purchaser assumes all responsibility for proper handling, storage, and use in accordance with applicable laws and regulations. All products sold on this website are for research use only and are not intended for human or animal consumption, medical, or diagnostic purposes. By purchasing, the buyer agrees to use products solely for lawful laboratory research and assumes all responsibility for proper handling and use in accordance with applicable laws and regulations.